🇺🇸 FDA
Patent

US 6830749

Recombinant P53 adenovirus methods and compositions

expired A61KA61K38/00A61K38/1709

Quick answer

US patent 6830749 (Recombinant P53 adenovirus methods and compositions) held by The Board of Regents of the University of Texas System expires Mon Dec 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 14 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K38/00, A61K38/1709, A61K48/00, A61P